JOHNSON & JOHNSON

JOHNSON & JOHNSON

Industry:
Healthcare

Founded:
1/1/1886

Address:
One Johnson & Johnson Plaza, New Brunswick, NJ, United States Zipcode 08933

Country:
United States

Phone:
732 524 0400

Revenue:
82.58 B
Total Assets:
174.89 B
Total Cash:
13.99 B

Founders: Edward Mead Johnson · Robert Wood Johnson I

Corporate leaders

Alex Gorsky_image

Alex Gorsky
CEO, Board of Directors, Chairman

Joseph J. Wolk_image

Joseph J. Wolk
Executive VP, CFO

Peter Fasolo, Ph.d._image

Peter Fasolo, Ph.d.
Chief Huma…
Related people

Alex Gorsky_image

Alex Gorsky
CEO

Robert Wood Johnson I_image

Robert Wood Johnson I
Founder

James Wood Johnson_image

James Wood Johnson

Robert Wood Johnson II_image

Robert Wood Johnson II

Edward Mead Johnson_image

Edward Mead Johnson
Founder

Johnson & Johnson_logo

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL ... brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.


Key Executives
Name Title Pay Year Born
Mr. Alex Gorsky Chairman & CEO 4,999,325$ 1960(60 years old)
Mr. Joseph J. Wolk CPA Exec. VP & CFO 1,976,200$ 1967(53 years old)
Dr. Paulus A. Stoffels Chief Scientific Officer 3,361,844$ 1962(58 years old)
Mr. Joaquin Duato Vice Chairman of Exec. Committee 2,887,910$ 1963(57 years old)
Ms. Jennifer L. Taubert Exec. VP & Worldwide Chairman of Pharmaceuticals 1,921,544$ 1964(56 years old)
Mr. Robert J. Decker Jr. Controller & Chief Accounting Officer N/A 1972(48 years old)
Mr. James Swanson Exec. VP & Global CIO N/A N/A
Mr. Christopher DelOrefice VP of Investor Relations N/A N/A
Mr. Michael H. Ullmann Exec. VP & Gen. Counsel N/A 1959(61 years old)
Ms. Ashley Watson Chief Compliance Officer N/A 1969(51 years old)

Stock Details

Company's stock symbol is JNJ. Lastest price : 163.62$. Total volume :5.63M Click reload if you want to check the lastest price on market!!!
Exchange NYSE. Currency in USD. Market state PRE

Johnson & Johnson (JNJ)
Last Price
163.62$
Change
-0.22$ (-0.13%)
Volume
5.63M

Previous Close163.84
Open163.71
Day Range163.29-164.03
Bid0.00 x 800
Ask0.00 x 800
Volume5.63M
Average Volume7.18M
Market Cap430.88B
Beta0.71
52 Week Range133.65-173.65
Trailing P/E28.90
Foward P/E15.70
Dividend (Yield %)2.59%
Ex-Dividend Date2021-05-24
Other Johnson & Johnson stocks:
Stock Symbol Exchange Currency Lastest Price Market Change Market Volume
JNJ.MX MEX MXN 3,337.00$ -13.27$ (-0.40%) N/A
JNJ.BA BUE ARS 5,528.50$ 113.50$ (2.10%) 1.22k
JNJ.SN SGO USD 163.33$ -0.67$ (-0.41%) N/A
JNJ.F FRA EUR 137.38€ -0.02€ (-0.01%) 451.00
JNJ.VI VIE EUR 137.42€ -0.30€ (-0.22%) 15.00
JNJ.DE GER EUR 137.14€ -0.52€ (-0.38%) 577.00
JNJB34.SA SAO BRL 54.07R$ -0.69R$ (-1.26%) N/A
JNJ-U.TI TLO N/A 137.10 -0.62 (-0.45%) 198.00


Financial Details

According to Johnson & Johnson's financial reports the company's revenue in 2021 were 82.58B an increase(0%) over the years 2019 revenue that were of 82.06B. In 2021 the company's total earnings were 14.71B while total earnings in 2019 were 15.12B(-6.67%).


Loading ...


Site Inspections: http://www.jnj.com

  • Host name: ec2-52-207-88-188.compute-1.amazonaws.com
  • IP address: 52.207.88.188
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...
Loading ...


More informations about "Johnson & Johnson" on Search Engine

About Johnson & Johnson | Johnson & Johnson

Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.

Jnj.com Go URL

About Johnson & Johnson | Johnson & Johnson

Your use of the information on this site is subject to the terms of our Legal Notice. …

Jnj.com Go URL

About Johnson & Johnson | Johnson & Johnson

Johnson & Johnson is a company of enduring strength. We've been privileged to play a …

Jnj.com Go URL

Johnson & Johnson’s Janssen COVID-19 Vaccine Overview and ...

Jun 01, 2021 · Johnson & Johnson’s Janssen COVID-19 Vaccine: The Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) recommend that use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine resume in the United States, effective April 23, 2021.However, women younger than 50 years old should especially be aware of the rare risk of blood …

Cdc.gov Go URL

Johnson & Johnson - Wikipedia

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit ratingof AAA, higher th…

En.wikipedia.org Go URL

Homepage | Johnson & Johnson

Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.

Jnj.com Go URL

Administration Overview for Johnson & Johnson's Janssen ...

Janssen COVID-19 Vaccine (Johnson & Johnson): Effective April 23, 2021, CDC and FDA recommend that use of the Janssen COVID-19 Vaccine resume in the United States. However, women younger than 50 years old especially should be made aware of a rare risk of blood clots with low platelets following vaccination and the availability of other COVID-19 vaccines where this risk has not been observed.

Cdc.gov Go URL

What you need to know about the Johnson & Johnson vaccine ...

Mar 03, 2021 · The Johnson & Johnson vaccine is a nonreplicating viral vector vaccine, a method with decades of research behind it. This vaccine uses adenovirus, a common cold virus that, when modified, is able to enter cells but can't make new virus particles. Researchers add the gene for the coronavirus spike protein—the protein on the surface of SARS-CoV ...

Hub.jhu.edu Go URL

The facts you should know about the Johnson & Johnson ...

Mar 24, 2021 · The Johnson & Johnson vaccine, authorized for emergency use on Feb. 27, differs from the vaccines developed by Pfizer-BioNTech and Moderna in important ways, though all three are considered highly effective and safe. First, the Johnson & Johnson vaccine is administered in just a single dose, while the other vaccines require that two doses be ...

Newsroom.ucla.edu Go URL

Facts About the Johnson and Johnson Vaccine

Jun 03, 2021 · The Johnson and Johnson COVID-19 vaccine is the third COVID-19 vaccine that the Food and Drug Administration (FDA) authorized for emergency use. That …

Healthline.com Go URL

Janssen COVID-19 Vaccine EUA Fact Sheet for Recipients and ...

This Fact Sheet contains information to help you understand the risks and benefits of receiving the -Janssen COVID19 Vaccine, which you may receive because there is currently a pandemic of COVID-19.

Fda.gov Go URL

High Hopes for Johnson & Johnson’s Covid Vaccine Have ...

Jun 18, 2021 · Johnson & Johnson’s decline in the United States has dovetailed with decreasing demand for Covid vaccines overall. Nearly 30 million doses of …

Nytimes.com Go URL

A history of Johnson & Johnson - pharmaphorum

Feb 26, 2021 · By most measures the single largest pharma company in the world, US-based Johnson & Johnson is also arguably one of the most well-known drugmakers among the general public. Behind household name ...

Pharmaphorum.com Go URL

Janssen COVID-19 Vaccine | FDA

Jun 15, 2021 · Janssen COVID-19 Vaccine. April 23, 2021: The FDA amended the emergency use authorization of the Johnson & Johnson (Janssen) COVID-19 vaccine to include information about a very rare and serious ...

Fda.gov Go URL

Johnson & Johnson COVID-19 Vaccine Risks and Benefits

The Johnson & Johnson . covid-19. vaccine. In people who developed these blood clots, symptoms began . approximately . 1–2. weeks after vaccination and most were women under . 50. years of age. You should seek . medical attention right away if you have any of the vaccine: shortness of breath, chest pain, leg swelling persistent abdominal pain ...

Cdph.ca.gov Go URL

Johnson & Johnson - Technology and Operations Management

Dec 08, 2015 · The alignment of Johnson & Johnson’s business model and operating model has been key to company’s 100-plus year’s of success. J&J’s operating model focused on decentralized management allows the company to effectively deliver on its business model – one focused on providing value through a diversified set of products and services to a ...

Digital.hbs.edu Go URL

Johnson & Johnson Consumer Inc. Company Information ...

Nov 26, 2008 · Drugs Associated with Johnson & Johnson Consumer Inc. Johnson & Johnson Consumer Inc. manufactures, markets and/or distributes more than 67 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.

Drugs.com Go URL

Stock Information | Johnson & Johnson

Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.

Investor.jnj.com Go URL

Johnson & Johnson COVID-19 vaccine - Wikipedia

The Janssen or Johnson & Johnson COVID-19 vaccine is a COVID-19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, subsidiary of American company Johnson & Johnson.. It is a viral vector vaccine based on a human adenovirus that has been modified to contain the gene for making the spike protein of the SARS-CoV …

En.wikipedia.org Go URL

Janssen COVID-19 Vaccine Official Website

If you need additional help submitting a report you may call the VAERS toll free information line at 1-800-822-7967. 1-800-822-7967. or send an email to [email protected] Report adverse events to Janssen Biotech, Inc. by calling 1-800-565-4008. 1-800-565-4008.

Janssencovid19vaccine.com Go URL